HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $275,000 | +51.1% | 65,136 | -0.4% | 0.10% | +56.9% |
Q2 2022 | $182,000 | -54.4% | 65,389 | -6.3% | 0.06% | -45.4% |
Q1 2022 | $399,000 | -5.0% | 69,759 | +51.6% | 0.12% | +1.7% |
Q4 2021 | $420,000 | -23.4% | 46,023 | -10.2% | 0.12% | -32.0% |
Q3 2021 | $548,000 | -31.1% | 51,247 | 0.0% | 0.17% | -26.2% |
Q2 2021 | $795,000 | -4.3% | 51,247 | -0.0% | 0.23% | -9.7% |
Q1 2021 | $831,000 | -23.2% | 51,270 | +0.3% | 0.26% | -32.6% |
Q4 2020 | $1,082,000 | +57.0% | 51,115 | +9.9% | 0.38% | +33.0% |
Q3 2020 | $689,000 | +1.2% | 46,490 | +0.4% | 0.29% | +1.4% |
Q2 2020 | $681,000 | +24.7% | 46,318 | -0.5% | 0.28% | +4.4% |
Q1 2020 | $546,000 | -49.3% | 46,535 | +1.5% | 0.27% | -40.5% |
Q4 2019 | $1,077,000 | +27.6% | 45,846 | +0.5% | 0.46% | +22.2% |
Q3 2019 | $844,000 | -0.4% | 45,635 | +0.1% | 0.37% | +2.7% |
Q2 2019 | $847,000 | -23.2% | 45,567 | +1.0% | 0.36% | -24.2% |
Q1 2019 | $1,103,000 | – | 45,131 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |